Pages that link to "Q37739949"
Jump to navigation
Jump to search
The following pages link to Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection (Q37739949):
Displaying 50 items.
- Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysis (Q24186892) (← links)
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (Q24289511) (← links)
- Current Treatment Approaches to HCC with a Special Consideration to Transplantation (Q26740375) (← links)
- Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation (Q26746521) (← links)
- Utilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinoma (Q26748807) (← links)
- Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma (Q26767346) (← links)
- Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress? (Q26769973) (← links)
- Risk Factors for the Development of Hepatocellular Carcinoma in Thailand (Q26775650) (← links)
- Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma (Q26781477) (← links)
- Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways (Q26783372) (← links)
- Immunology of hepatocellular carcinoma (Q26795411) (← links)
- Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma (Q26795529) (← links)
- DPP4 in Diabetes (Q26797335) (← links)
- Biological features and biomarkers in hepatocellular carcinoma (Q26799462) (← links)
- Mitochondrial fatty acid oxidation in obesity (Q26820838) (← links)
- AEG-1/MTDH/LYRIC in liver cancer (Q26822570) (← links)
- Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan (Q26824416) (← links)
- Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease (Q26825517) (← links)
- Lessons from mouse models of high-fat diet-induced NAFLD (Q26829532) (← links)
- Exposure to ambient air particulate matter and non-alcoholic fatty liver disease (Q26997401) (← links)
- Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population (Q27003363) (← links)
- Functional roles of protein nitration in acute and chronic liver diseases (Q27008888) (← links)
- Role of microRNAs in hepatocellular carcinoma: a clinical perspective (Q27014034) (← links)
- The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis (Q27319729) (← links)
- Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease (Q28066100) (← links)
- Hepatocellular carcinoma in nonalcoholic fatty liver disease mimicking benign hemangioma: two case reports and literature review (Q28077023) (← links)
- Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets (Q28079713) (← links)
- NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed? (Q28079900) (← links)
- Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model (Q28268632) (← links)
- Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges (Q28272678) (← links)
- Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations (Q28386598) (← links)
- Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice (Q28389770) (← links)
- The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma (Q28392224) (← links)
- Environmental pollution: a tangible risk for NAFLD pathogenesis (Q28661241) (← links)
- Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature (Q30234443) (← links)
- Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management (Q30234574) (← links)
- Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine (Q30301218) (← links)
- Cost-utility analysis of nonalcoholic steatohepatitis screening. (Q30385602) (← links)
- The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. (Q30399200) (← links)
- Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation (Q30402324) (← links)
- Obesity, adipokines and hepatocellular carcinoma (Q30427127) (← links)
- MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma (Q30439971) (← links)
- Inflammation in nonalcoholic steatohepatitis (Q30453231) (← links)
- Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States (Q30584496) (← links)
- Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. (Q33396838) (← links)
- Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma (Q33397694) (← links)
- Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma (Q33554179) (← links)
- Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease (Q33580624) (← links)
- Endpoints and clinical trial design for nonalcoholic steatohepatitis (Q33583798) (← links)
- Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis (Q33585588) (← links)